An introduction to pancreatic adenocarcinoma genetics, pathology and therapy

Scott E Kern, Ralph H Hruban, Manuel Hidalgo, Charles J. Yeo

Research output: Contribution to journalArticle

Abstract

Cancer is bad, but pancreatic cancer is especially so. Underlying the aggressive behavior of pancreatic cancer is a highly patterned set of biologic rules for its development. The accumulating discoveries regarding the genetic basis of pancreatic cancer and developments in the clinical management of the disease provide hope for meaningful improvements in the understanding and control of this disease.

Original languageEnglish (US)
Pages (from-to)607-613
Number of pages7
JournalCancer Biology and Therapy
Volume1
Issue number6
StatePublished - Nov 2002

Fingerprint

Pancreatic Neoplasms
Genetic Therapy
Adenocarcinoma
Pathology
Disease Management
Neoplasms

Keywords

  • BRCA2 mutations
  • Cancer precursors
  • Familial cancer
  • Genetic mutations
  • Mitomycin C
  • Pancreatic cancer
  • Pancreaticoduodenectomy
  • Telomeres

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. / Kern, Scott E; Hruban, Ralph H; Hidalgo, Manuel; Yeo, Charles J.

In: Cancer Biology and Therapy, Vol. 1, No. 6, 11.2002, p. 607-613.

Research output: Contribution to journalArticle

@article{c57c8579aef94a1eae9ee8c4136e2a61,
title = "An introduction to pancreatic adenocarcinoma genetics, pathology and therapy",
abstract = "Cancer is bad, but pancreatic cancer is especially so. Underlying the aggressive behavior of pancreatic cancer is a highly patterned set of biologic rules for its development. The accumulating discoveries regarding the genetic basis of pancreatic cancer and developments in the clinical management of the disease provide hope for meaningful improvements in the understanding and control of this disease.",
keywords = "BRCA2 mutations, Cancer precursors, Familial cancer, Genetic mutations, Mitomycin C, Pancreatic cancer, Pancreaticoduodenectomy, Telomeres",
author = "Kern, {Scott E} and Hruban, {Ralph H} and Manuel Hidalgo and Yeo, {Charles J.}",
year = "2002",
month = "11",
language = "English (US)",
volume = "1",
pages = "607--613",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - An introduction to pancreatic adenocarcinoma genetics, pathology and therapy

AU - Kern, Scott E

AU - Hruban, Ralph H

AU - Hidalgo, Manuel

AU - Yeo, Charles J.

PY - 2002/11

Y1 - 2002/11

N2 - Cancer is bad, but pancreatic cancer is especially so. Underlying the aggressive behavior of pancreatic cancer is a highly patterned set of biologic rules for its development. The accumulating discoveries regarding the genetic basis of pancreatic cancer and developments in the clinical management of the disease provide hope for meaningful improvements in the understanding and control of this disease.

AB - Cancer is bad, but pancreatic cancer is especially so. Underlying the aggressive behavior of pancreatic cancer is a highly patterned set of biologic rules for its development. The accumulating discoveries regarding the genetic basis of pancreatic cancer and developments in the clinical management of the disease provide hope for meaningful improvements in the understanding and control of this disease.

KW - BRCA2 mutations

KW - Cancer precursors

KW - Familial cancer

KW - Genetic mutations

KW - Mitomycin C

KW - Pancreatic cancer

KW - Pancreaticoduodenectomy

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=0038650956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038650956&partnerID=8YFLogxK

M3 - Article

C2 - 12642681

AN - SCOPUS:0038650956

VL - 1

SP - 607

EP - 613

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 6

ER -